Erbi Biosystems, a part of MilliporeSigma

MilliporeSigma, a leading science and technology company, has acquired (in December 2022) Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the Mobius Breez Microbioreactor. The deal strengthens Millipore Sigma upstream portfolio in therapeutic proteins by enabling scalable cell-based perfusion bioreactor processes from 2ml to 2000L with rapid lab-scale process development. To learn more on Mobius Breez Microbioreactor visit: https://www.sigmaaldrich.com/FR/en/products/pharma-and-biopharma-manufacturing/bioprocessing-cell-culture/single-use-bioreactors

Microbioreactor,cell process development,perfusion culture,perfusion culture for mammalian process development,continuous culture,and automation

Erbi biosystems, a part of milliporesigma operates in the Biotechnology industry.

Erbi biosystems, a part of milliporesigma's revenue is 11m - 100m

Erbi biosystems, a part of milliporesigma has 11 - 50 employees.